Opti Capital Management, LP - Q2 2023 holdings

$1.18 Billion is the total value of Opti Capital Management, LP's 49 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
 CHART INDS INCnote 1.000%11/1$83,469,773
+25.7%
30,367,0000.0%7.06%
+31.5%
 INSIGHT ENTERPRISES INCnote 0.750% 2/1$66,399,745
+2.7%
30,836,0000.0%5.61%
+7.4%
 8X8 INC NEWnote 4.000% 2/0$25,124,831
-0.2%
28,537,0000.0%2.12%
+4.4%
 VERINT SYSTEMS INCnote 0.250% 4/1$19,912,500
-0.5%
22,500,0000.0%1.68%
+4.0%
 FIVERR INTL LTDnote 11/0$19,054,119
+1.4%
22,476,0000.0%1.61%
+6.1%
 HEALTH CATALYST INCnote 2.500% 4/1$17,383,413
+4.3%
18,155,0000.0%1.47%
+9.1%
 NEVRO CORPnote 2.750% 4/0$16,531,498
+0.6%
17,500,0000.0%1.40%
+5.3%
 I3 VERTICALS LLCnote 1.000% 2/1$14,800,000
-1.3%
16,000,0000.0%1.25%
+3.2%
 Q2 HLDGS INCnote 0.125%11/1$6,063,875
+5.1%
6,950,0000.0%0.51%
+10.1%
 INFINERA CORPdebt 3.750% 8/0$3,516,415
-25.9%
3,500,0000.0%0.30%
-22.7%
 SPLUNK INCnote 0.500% 9/1$2,964,375
+0.6%
3,000,0000.0%0.25%
+5.5%
FWONK  LIBERTY MEDIA CORP DEL$412,713
-1.1%
5,5760.0%0.04%
+2.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Opti Capital Management, LP's complete filings history.

Compare quarters

Export Opti Capital Management, LP's holdings